Business
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules.
About this update from Axim Biotechnologies, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules\nPR Newswire\nSAN DIEGO, May 5, 2020\n\n\n\nSAN DIEGO, May 5, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (\"AXIM® Biotech\" or \"AXIM\") has filed an application with the United States Patent and Trademark Office (USPTO) for a patent on water-soluble cannabinoid molecules. \nAXIM has created new molecular entities with cannabinoids as the centerpiece that are significantly higher in water solubility than naturally occurring cannabinoids. Specifically, the Company has created a super cannabidiol (CBD) molecule using a reaction pathway resulting in high yield of the product. Preliminary studies show that this super CBD molecule is expected to be at least 338 times more water-soluble than naturally occurring CBD. AXIM also found similar reaction pathways for creating multi-cannabinoid molecules, where different cannabinoids are incorporated into one chemical entity.\n\"We are known for innovation, pushing the limits and making history for the CBD industry,\" said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. \"With AXIM's new super CBD-like molecule, our family of companies is showing that we intend to keep growing that reputation.\"\nThrough this invention, AXIM is providing a solution to several challenges that scientists currently face in the development of cannabinoid products and therapies. First, AXIM's scientists are increasing cannabinoid solubility while maintaining the cannabinoid molecule's active ...